Morphine: pharmacokinetics and clinical practice
1990
Understanding Morphine for Cancer Pain
Editorial
Author Information
Author(s): P.J. Hoskin, G.W. Hanks
Primary Institution: The Royal Marsden Hospital
Hypothesis
What are the pharmacokinetics of morphine and how do they affect its clinical use in cancer pain management?
Conclusion
Knowledge of morphine's pharmacokinetics is crucial for effective pain management in cancer patients.
Supporting Evidence
- Morphine is the most commonly used strong painkiller for cancer patients.
- Patients may need very different doses of morphine to manage their pain.
- Some patients may experience side effects that prevent them from using morphine.
Takeaway
Morphine helps with cancer pain, but how it works in the body can be very different for each person.
Limitations
There is limited knowledge about morphine's pharmacokinetics and its effects can vary widely among individuals.
Want to read the original?
Access the complete publication on the publisher's website